Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort

Collapse authors list.
Song, Yong, Hu, Chengping, Xie, Zhanhong, Wu, Lin, Zhu, Zhengfei, Rao, Chuangzhou, Liu, Li, Chen, Yuan, Liang, Naixin, Chen, Jun et al (show 24 more authors) , Hu, Chunhong, Yang, Nong, Hu, Jie, Zhao, Weixin, Tong, Gangling, Dong, Xiaorong, Zheng, Di, Jin, Meiling, Chen, Jianhua, Huang, Meijuan, He, Yong, Rosell, Rafael, Lippi, Giuseppe, Mino-Kenudson, Mari, Han-Zhang, Han, Mao, Xinru, Zhang, Lu, Liu, Hao, Field, John K ORCID: 0000-0003-3951-6365, Chuai, Shannon, Ye, Junyi, Han, Yusheng, Lu, Shun and Grp, AME Lung Canc Collaborative (2020) Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort. TRANSLATIONAL LUNG CANCER RESEARCH, 9 (2). 269 - +.

Access the full-text of this item by clicking on the Open Access link.

Text Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort-.pdf - Author Accepted Manuscript Download (253kB) | Preview

Item Type:	Article
Uncontrolled Keywords:	Circulating tumor DNA (ctDNA), circulating tumor DNA clearance (ctDNA clearance), liquid biopsy, non-small cell lung cancer (NSCLC)
Depositing User:	Symplectic Admin
Date Deposited:	18 May 2020 09:24
Last Modified:	05 Oct 2022 22:06
DOI:	10.21037/tlcr.2020.03.17
Open Access URL:	http://10.0.82.45/tlcr.2020.03.17
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3087809